Developing a discrimination rule between breast cancer patients and controls using proteomics mass spectrometric data: a three-step approach

DOI10.2202/1544-6115.1341MaRDI QIDQ2864014zbMATH OpenOpenAlexWikidataFDO

Authors A. Geert Heidema, Nico Nagelkerke

Publication date 5 December 2013

Published in Statistical Applications in Genetics and Molecular Biology (Search for Journal in Brave)

Full work available at URL https://doi.org/10.2202/1544-6115.1341

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50)

Recommendations

• Breast cancer diagnosis from proteomic mass spectrometry data: a comparative evaluation
• Case-control breast cancer study of MALDI-TOF proteomic mass spectrometry data on serum samples
• Reproducibility of biomarker identifications from mass spectrometry proteomic data in cancer studies
• Classification of breast cancer versus normal samples from mass spectrometry profiles using linear discriminant analysis of important features selected by random forest
• A cross-validation study to select a classification procedure for clinical diagnosis based on proteomic mass spectrometry
• A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection
• Predicting patient survival from proteomic profile using mass spectrometry data: an empirical study
• Feature selection and machine learning with mass spectrometry data for distinguishing cancer and non-cancer samples
• Detection of cancer-specific markers amid massive mass spectral data

Cited in

(8)

• On the use of double cross-validation for the combination of proteomic mass spectral data for enhanced diagnosis and prediction
• A classification model for the Leiden proteomics competition
• Classification of breast cancer versus normal samples from mass spectrometry profiles using linear discriminant analysis of important features selected by random forest
• Bayesian nonparametric classification for spectroscopy data
• Support vector machine approach to separate control and breast cancer serum samples
• Case-control breast cancer study of MALDI-TOF proteomic mass spectrometry data on serum samples
• Breast cancer diagnosis from proteomic mass spectrometry data: a comparative evaluation
• Binary Markov random fields and interpretable mass spectra discrimination

This page was built for publication: Developing a discrimination rule between breast cancer patients and controls using proteomics mass spectrometric data: a three-step approach

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2864014)